This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Verthelyi, D Articles by Klinman, D M Search for Related Content PubMed PubMed Citation Articles by Verthelyi, D Articles by Klinman, D M Social Bookmarking                         What's this?

Disassociation of sex hormone levels and cytokine production in SLE patients

Retroviral Immunology Section, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA; Bldg 29A Rm 3 D 2, CBER/FDA, Bethesda, MD 20892, USA verthelyi{at}CBER.FDA.GOV

M Petri

M Ylamus

Division of Rheumatology of the Johns Hopkins University School of Medicine, Baltimore, MD, USA

D M Klinman

Retroviral Immunology Section, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA

This study examines whether changes in the cytokine milieu of patients with systemic lupus erythematosus (SLE) are associated with abnormal levels of sex hormone levels in serum. The concentration of 17b-estradiol (E2), progesterone (Pg) and dehydroepiandrosterone-sulphate (DHEAS) was monitored in sera from 128 lupus patients and 96 controls, and correlated with the activity of their cytokine secreting cells.

Results indicate that SLE patients have (i) significantly fewer cells secreting IFNg, (ii) increased serum E2 and Pg levels, and (iii) reduced serum DHEAS levels compared to normal controls. However, the observed abnormalities in the cytokine milieu of SLE patients did not correlate with abnormalities in serum sex hormone levels. Instead, the association between IFNg production and DHEAS levels evident in healthy controls is absent in SLE patients, suggesting that cells from lupus patients are defective in their ability to produce IFNg in response to physiologic stimuli. Similarly, the normal correlation between IL-4 production and E2 levels was lost in patients with severe disease. Thus, while it remains possible that increased E2 and reduced DHEAS levels in lupus patients may help induce cytokine abnormalities early in disease, the subsequent cytokine imbalance does not correlate with sex hormone levels.

Key Words: estrogen • dehydroepiandrosterone-sulphate • cytokines • systemic lupus erythematosus

Lupus, Vol. 10, No. 5, 352-358 (2001)
DOI: 10.1191/096120301674365881


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. Fairweather, S. Frisancho-Kiss, and N. R. Rose Sex Differences in Autoimmune Disease from a Pathological Perspective Am. J. Pathol., September 1, 2008; 173(3): 600 - 609. [Abstract] [Full Text] [PDF]

				M Petri Sex hormones and systemic lupus erythematosus Lupus, May 1, 2008; 17(5): 412 - 415. [Abstract] [PDF]

				P. Kocis Prasterone Am. J. Health Syst. Pharm., November 15, 2006; 63(22): 2201 - 2210. [Abstract] [Full Text] [PDF]

				L. S. Ackerman Sex hormones and the genesis of autoimmunity. Arch Dermatol, March 1, 2006; 142(3): 371 - 376. [Abstract] [Full Text] [PDF]

				R. A. Zeuner, D. M. Klinman, G. Illei, C. Yarboro, K. J. Ishii, M. Gursel, and D. Verthelyi Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides Rheumatology, April 1, 2003; 42(4): 563 - 569. [Abstract] [Full Text] [PDF]